Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.

Blood-retinal barrier (BRB) breakdown is a hallmark of diabetic retinopathy, but the molecular changes that cause this pathology are unclear. Occludin is a transmembrane component of interendothelial tight junctions that may regulate permeability at the BRB. In this study, we examined the effects of vascular endothelial growth factor (VEGF) and diabetes on vascular occludin content and barrier function. Sprague-Dawley rats were made diabetic by intravenous streptozotocin injection, and age-matched animals served as controls. After 3 months, BRB permeability was quantified by intravenous injection of fluorescein isothiocyanate-bovine serum albumin (FITC-BSA), Mr 66 kDa, and 10-kDa rhodamine-dextran (R-D), followed by digital image analysis of retinal sections. Retinal fluorescence intensity for FITC-BSA increased 62% (P < or = 0.05), but R-D fluorescence did not change significantly. Occludin localization at interendothelial junctions was confirmed by immunofluorescence, and relative protein content was determined by immunoblotting of retinal homogenates. Retinal occludin content decreased approximately 35% (P < or = 0.03) in the diabetic versus the control animals, whereas the glucose transporter GLUT1 content was unchanged in rat retinas. Additionally, treatment of bovine retinal endothelial cells in culture with 0.12 nmol/l or 12 nmol/l VEGF for 6 h reduced occludin content 46 and 54%, respectively. These data show that diabetes selectively reduces retinal occludin protein expression and increases BRB permeability. Our findings suggest that the elevated VEGF in the vitreous of patients with diabetic retinopathy increases vascular permeability by downregulating occludin content. Decreased tight junction protein expression may be an important means by which diabetes causes increased vascular permeability and contributes to macular edema.

[1]  A. Barber,et al.  Astrocytes increase barrier properties and ZO-1 expression in retinal vascular endothelial cells. , 1997, Investigative ophthalmology & visual science.

[2]  Hidehiro Ishii,et al.  Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor , 1997, Diabetes.

[3]  D. Paul,et al.  COOH Terminus of Occludin Is Required for Tight Junction Barrier Function in Early Xenopus Embryos , 1997, The Journal of cell biology.

[4]  L. Rubin,et al.  Occludin as a possible determinant of tight junction permeability in endothelial cells. , 1997, Journal of cell science.

[5]  C. V. Van Itallie,et al.  Occludin confers adhesiveness when expressed in fibroblasts. , 1997, Journal of cell science.

[6]  A. P. Soler,et al.  Different size limitations for increased transepithelial paracellular solute flux across phorbol ester and tumor necrosis factor‐treated epithelial cell sheets , 1997, Journal of cellular physiology.

[7]  B. Gumbiner,et al.  A Synthetic Peptide Corresponding to the Extracellular Domain of Occludin Perturbs the Tight Junction Permeability Barrier , 1997, The Journal of cell biology.

[8]  T. Gardner,et al.  Histamine reduces ZO-1 tight-junction protein expression in cultured retinal microvascular endothelial cells. , 1996, The Biochemical journal.

[9]  R. D. Lynch,et al.  Occludin is a functional component of the tight junction. , 1996, Journal of cell science.

[10]  M. Balda,et al.  Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical- basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein , 1996, The Journal of cell biology.

[11]  G. Lutty,et al.  Localization of vascular endothelial growth factor in human retina and choroid. , 1996, Archives of ophthalmology.

[12]  K. Nakagawa,et al.  The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[13]  C. V. Van Itallie,et al.  Tight junctions and the molecular basis for regulation of paracellular permeability. , 1995, The American journal of physiology.

[14]  L. Aiello,et al.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.

[15]  H. Parving,et al.  Probenecid inhibition of the outward transport of fluorescein across the human blood‐retina barrier , 1994, Acta ophthalmologica.

[16]  M. Itoh,et al.  Occludin: a novel integral membrane protein localizing at tight junctions , 1993, The Journal of cell biology.

[17]  P. Campochiaro,et al.  Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[18]  R. Poulsom,et al.  Effects of long-term diabetes and galactosaemia upon lens and retinal mRNA levels in the rat. , 1990, Experimental eye research.

[19]  T. Gardner,et al.  Histamine H1 receptors mediate increased blood-retinal barrier permeability in experimental diabetes. , 1989, Archives of ophthalmology.

[20]  W. J. Carroll,et al.  Retinal histamine synthesis is increased in experimental diabetes. , 1988, Investigative ophthalmology & visual science.

[21]  S. Schaeffer,et al.  The structural basis of the inner blood-retina barrier in the eye of Macaca mulatta. , 1987, Investigative ophthalmology & visual science.

[22]  C. Kilo,et al.  Increased Vascular Permeability in Spontaneously Diabetic BB/W Rats and in Rats With Mild Versus Severe Streptozocin-Induced Diabetes: Prevention by Aldose Reductase Inhibitors and Castration , 1987, Diabetes.

[23]  D. Rotrosen,et al.  Histamine type I receptor occupancy increases endothelial cytosolic calcium, reduces F-actin, and promotes albumin diffusion across cultured endothelial monolayers , 1986, The Journal of cell biology.

[24]  S. Weinbaum,et al.  Effect of cell turnover and leaky junctions on arterial macromolecular transport. , 1985, The American journal of physiology.

[25]  M. Tso,et al.  Pathologic studies of the blood--retinal barrier in the spontaneously diabetic BB rat. , 1984, Investigative ophthalmology & visual science.

[26]  I. Wallow.  Posterior and anterior permeability defects? Morphologic observations on streptozotocin-treated rats. , 1983, Investigative ophthalmology & visual science.

[27]  C. Mogensen,et al.  The Stages in Diabetic Renal Disease: With Emphasis on the Stage of Incipient Diabetic Nephropathy , 1983, Diabetes.

[28]  R. McCuskey,et al.  Selective Extravascular Escape of Albumin into the Cerebral Cortex of the Diabetic Rat , 1981, Diabetes.

[29]  A. Laties,et al.  Early morphological alteration of the pigment epithelium in streptozotocin-induced diabetes: increased surface area of the basal cell membrane. , 1980, Experimental eye research.

[30]  T. Ishibashi,et al.  Disruption of blood-retinal barrier in experimental diabetic rats: an electron microscopic study. , 1980, Experimental eye research.

[31]  I. Wallow,et al.  Permeability and patency of retinal blood vessels in experimental diabetes. , 1977, Investigative ophthalmology & visual science.

[32]  J. Cunha-Vaz,et al.  Early breakdown of the blood-retinal barrier in diabetes. , 1975, The British journal of ophthalmology.

[33]  D. Eliott,et al.  Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. , 1997, Investigative ophthalmology & visual science.

[34]  A. Barber,et al.  Agrin accumulates in the brain microvascular basal lamina during development of the blood-brain barrier. , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.

[35]  T. Gardner.  Histamine ZO-1 and blood-retinal barrier permeability in diabetic retinopathy , 1996 .